ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oldenburg, O.
Right arrow Articles by Horstkotte, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oldenburg, O.
Right arrow Articles by Horstkotte, D.
Eur Respir J 2007; 30:1023
Copyright ©ERS Journals Ltd 2007

Screening for sleep-disordered breathing is recommended in patients with chronic heart failure

O. Oldenburg, B. Lamp, G. Freudenberg and D. Horstkotte

Dept of Cardiology, Heart and Diabetes Centre North Rhine–Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany.

To the Editors:

In a recent editorial in the European Respiratory Journal, K.A. Franklin criticised the screening of heart failure patients for sleep-disordered breathing (SDB) 1. The major concern was that, to date, no beneficial effect on overall prognosis has been shown for any therapeutic option, e.g. nocturnal oxygen, continuous positive airway pressure (CPAP) or adaptive servoventilation (ASV).

The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure (CANPAP) trial was the first study to assess the effect of CPAP therapy in patients with chronic heart failure (CHF) and predominantly central sleep apnoea (CSA) on mortality 2. Unfortunately, this study failed to demonstrate a prognostic benefit. However, there is ongoing debate as to how to interpret the CANPAP trial results, but there might be a consensus that CPAP cannot be recommended for all CHF patients with CSA as performed in this trial. There is no question that more evidence is needed as to how to treat SDB in patients with CHF. Several small studies have shown beneficial effects of oxygen, CPAP or ASV on parameters of SDB and/or CHF, but studies on mortality are pending. It seems likely that therapeutic approaches should be tailored to different types and severities of SDB (obstructive, central or mixed), and results may be dependent upon SDB and CHF severity.

Recently published studies have confirmed a high prevalence of SDB in patients with CHF treated according to current guidelines 3, 4. In addition, central types of SDB (periodic breathing or Cheyne–Stokes respiration) are supposed to be indicators of the severity of cardiac failure in selected patients. With worsening CHF, the number of central events increases, and sufficient heart failure therapy can improve CSA substantially 5, 6. Moreover, it has been shown that the presence of obstructive 7, as well as central 8, 9, types of SDB are associated with an impaired prognosis and increased morbidity in these patients. In this context, the apnoea/hypopnoea index represents a strong prognostic marker of future cardiac events 10. This implies that screening for SDB is warranted in order to identify at-risk patients and lead to intensified therapeutic efforts. Consequently, screening for SDB should be part of the routine work-up in CHF patients (such as, for example, spiroergometry) for the identification of at-risk patients and perhaps intensification of therapy.

With the availability of simplified and portable screening devices, we recommend screening for sleep-disordered breathing in every heart failure patient, and even use these devices for follow-up purposes. Diagnostic nihilism seems to be inappropriate, but studies on treatment modalities need to be performed.

REFERENCES

  1. Franklin KA. Sleep apnoea screening in heart failure? Not until benefit is proven!. Eur Respir J 2007;29:1073–1074.[Free Full Text]
  2. Bradley T, Logan A, Kimoff R, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025–2033.[Abstract/Free Full Text]
  3. Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Töpfer V. Sleep disordered breathing in patients with symptomatic heart failure. Eur J Heart Failure 2007;9:251–257.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  4. Schulz R, Blau A, Börgel J, et al. Sleep apnoea in heart failure. Eur Respir J 2007;29:1201–1205.[Abstract/Free Full Text]
  5. Oldenburg O, Faber L, Vogt J, et al. Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Failure 2007; 9: 820–826
  6. Sinha A, Skobel E, Breithardt OA, et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne–Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 2004;44:68–71.[Abstract/Free Full Text]
  7. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1625–1631.[Abstract/Free Full Text]
  8. Ancoli-Israel S, Engler R, Friedman P, Klauber M, Ross P, Kripke D. Comparison of patients with central sleep apnea with and without Cheyne–Stokes respiration. Chest 1994;106:780–786.[Web of Science][Medline] [Order article via Infotrieve]
  9. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007;49:2028–2034.[Abstract/Free Full Text]
  10. Corra U, Pistono M, Mezzani A, et al. Sleep and exertional periodic breathing in chronic heart failure. Prognostic importance and interdependence. Circulation 2006;113:44–50.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Eur J Heart FailHome page
O. Oldenburg, A. Schmidt, B. Lamp, T. Bitter, B. G. Muntean, C. Langer, and D. Horstkotte
Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration
Eur J Heart Fail, June 1, 2008; 10(6): 581 - 586.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oldenburg, O.
Right arrow Articles by Horstkotte, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oldenburg, O.
Right arrow Articles by Horstkotte, D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS